dabigatran has been researched along with Duodenal Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alhashem, HM; Avendano, C; Hayes, BD; Winters, ME | 1 |
1 other study(ies) available for dabigatran and Duodenal Diseases
| Article | Year |
|---|---|
Persistent life-threatening hemorrhage after administration of idarucizumab.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antidotes; Antithrombins; Atrial Fibrillation; Dabigatran; Duodenal Diseases; Embolization, Therapeutic; Gastrointestinal Hemorrhage; Humans; Male; Treatment Failure | 2017 |